These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2476592)
1. Electrophysiologic effects of Org 7797, a new steroidal antiarrhythmic agent: comparison with class 1a, 1b, and 1c drugs. Winslow E; Martorana M; Bell P J Cardiovasc Pharmacol; 1989 Aug; 14(2):205-12. PubMed ID: 2476592 [TBL] [Abstract][Full Text] [Related]
2. Comparative frequency-dependent effects of three class Ic agents, Org 7797, flecainide, and propafenone, on ventricular action potential duration. Winslow E; Campbell JK J Cardiovasc Pharmacol; 1991 Dec; 18(6):911-7. PubMed ID: 1725906 [TBL] [Abstract][Full Text] [Related]
3. Comparative effects of three class I antiarrhythmic drugs on plateau and pacemaker currents of sheep cardiac Purkinje fibres. Coraboeuf E; Deroubaix E; Escande D; Coulombe A Cardiovasc Res; 1988 Jun; 22(6):375-84. PubMed ID: 2852055 [TBL] [Abstract][Full Text] [Related]
4. Electrophysiologic effects of RS-2135, a new antiarrhythmic compound, on canine Purkinje fibers. Yorikane R; Sada T; Koike H J Cardiovasc Pharmacol; 1992 Dec; 20(6):955-60. PubMed ID: 1282599 [TBL] [Abstract][Full Text] [Related]
5. Barucainide, a novel class Ib antiarrhythmic agent with a slow kinetic property: electrophysiologic observations in isolated canine and rabbit cardiac muscle. Takanaka C; Singh BN Am Heart J; 1990 May; 119(5):1050-60. PubMed ID: 2330863 [TBL] [Abstract][Full Text] [Related]
6. Frequency- and voltage-dependent effects of disopyramide in canine Purkinje fibers. Flemming MA; Sasyniuk BI Can J Physiol Pharmacol; 1989 Jul; 67(7):710-21. PubMed ID: 2766102 [TBL] [Abstract][Full Text] [Related]
7. Differential effects on action potential duration of class IA, B and C antiarrhythmic drugs: modulation by stimulation rate and extracellular K+ concentration. Campbell TJ; Wyse KR; Pallandi R Clin Exp Pharmacol Physiol; 1991 Aug; 18(8):533-41. PubMed ID: 1655321 [TBL] [Abstract][Full Text] [Related]
8. Voltage- and rate-dependent depression of Vmax of action potentials by a new antiarrhythmic agent, E-0747, in swine cardiac Purkinje fibers. Sawada K; Shoji T; Igarashi T; Hiraoka M J Cardiovasc Pharmacol; 1987 Jan; 9(1):51-6. PubMed ID: 2434794 [TBL] [Abstract][Full Text] [Related]
9. Cellular electrophysiology of the new antiarrhythmic agent recainam (Wy-42,362) in canine cardiac Purkinje fibers. Colatsky TJ; Bird LB; Jurkiewicz NK; Wendt RL J Cardiovasc Pharmacol; 1987 Apr; 9(4):435-44. PubMed ID: 2438506 [TBL] [Abstract][Full Text] [Related]
10. Nicorandil shortens action potential duration and antagonises the reduction of Vmax by lidocaine but not by disopyramide in guinea-pig papillary muscles. Kojima M; Ban T Naunyn Schmiedebergs Arch Pharmacol; 1988 Feb; 337(2):203-12. PubMed ID: 2966899 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the electrophysiological effects of Org 7797, disopyramide, mexiletine and propafenone in anaesthetized dogs with myocardial infarcts. Campbell JK; Marshall RJ; Winslow E Br J Pharmacol; 1991 Oct; 104(2):433-9. PubMed ID: 1797309 [TBL] [Abstract][Full Text] [Related]
12. Frequency and voltage-dependent effects of mono-N-dealkyldisopyramide, the major metabolite of disopyramide, in canine ventricular tissue. Toy W; Sasyniuk BI J Pharmacol Exp Ther; 1990 Aug; 254(2):603-11. PubMed ID: 2166798 [TBL] [Abstract][Full Text] [Related]
13. Electrophysiologic, inotropic and antiarrhythmic effects of propafenone, 5-hydroxypropafenone and N-depropylpropafenone. Malfatto G; Zaza A; Forster M; Sodowick B; Danilo P; Rosen MR J Pharmacol Exp Ther; 1988 Aug; 246(2):419-26. PubMed ID: 3404440 [TBL] [Abstract][Full Text] [Related]
14. Time course of the electrophysiological effects of quinidine on canine cardiac Purkinje fibers: concentration dependence and comparison with lidocaine and disopyramide. Nattel S; Bailey JC J Pharmacol Exp Ther; 1983 Apr; 225(1):176-80. PubMed ID: 6834270 [TBL] [Abstract][Full Text] [Related]
15. Combined application of class I antiarrhythmic drugs causes "additive", "reductive", or "synergistic" sodium channel block in cardiac muscles. Kawamura T; Kodama I; Toyama J; Hayashi H; Saito H; Yamada K Cardiovasc Res; 1990 Nov; 24(11):925-31. PubMed ID: 2176934 [TBL] [Abstract][Full Text] [Related]
16. Electrophysiologic effects of FPL 13210 on canine Purkinje fiber action potential duration and Vmax comparison to disopyramide. Knilans TK; Varró A; Nánási PP; Murray RJ; Kaiser FC; Lathrop DA Cardiovasc Drugs Ther; 1991 Feb; 5(1):139-46. PubMed ID: 2036332 [TBL] [Abstract][Full Text] [Related]
17. Properties of Vmax block of INa-mediated action potentials during combined application of antiarrhythmic drugs in cardiac muscle. Kohlhardt M; Seifert C Naunyn Schmiedebergs Arch Pharmacol; 1985 Sep; 330(3):235-44. PubMed ID: 2414674 [TBL] [Abstract][Full Text] [Related]
18. Frequency-independent blockade of cardiac Na+ channels by riluzole: comparison with established anticonvulsants and class I anti-arrhythmics. Mestre M; Djellas Y; Carriot T; Cavero I Fundam Clin Pharmacol; 2000; 14(2):107-17. PubMed ID: 10796057 [TBL] [Abstract][Full Text] [Related]
19. Combined effects of different class I antiarrhythmic agents on maximum rate of depolarization (Vmax) of action potentials in guinea-pig papillary muscles. Hiraoka M; Nitta J; Sunami A; Sawanobori T Cardiovasc Drugs Ther; 1991 Aug; 5 Suppl 4():791-9. PubMed ID: 1931756 [TBL] [Abstract][Full Text] [Related]
20. Combined class I antiarrhythmic agents have differential effects on tonic and use dependent block of maximum rate of depolarisation of action potentials in guinea pig cardiac muscle. Nitta J; Sunami A; Furukawa T; Marumo F; Sawanobori T; Hiraoka M Cardiovasc Res; 1992 May; 26(5):462-9. PubMed ID: 1332827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]